Toggle Health Problems and D

Following COVID vaccination 31% had neurological problems (Italy) – Oct 2023

NEURO-COVAX: Italian Network Finds Neurological Side Effects Very Common after COVID-19 Vaccination

McCullough substack
31.2% Experienced Tremors, Insomnia, Muscle Spasms, Headaches, Paresthesias, Vertigo, and Diplopia
The NEURO-COVAX-cohort included 19,108 vaccinated people:

  • 15,368 with BNT162b2 (Pfizer),
  • 2,077 with mRNA-1273,
  • 1,651 with ChAdOx1nCov-19

“A vulnerable clinical profile emerged, where over 40% of the symptomatic people showed comorbidities in their clinical histories. Defining the neurological risk profile, we found an increased risk for ChAdOx1nCov-19 of tremors (vs. BNT162b2, OR: 5.12, 95% CI: 3.51-7.48); insomnia (vs. mRNA-1273, OR: 1.87, 95% CI: 1.02-3.39); muscle spasms (vs. BNT162b2, OR: 1.62, 95% CI: 1.08-2.46); and headaches (vs. BNT162b2, OR: 1.49, 95% CI: 0.96-1.57). For mRNA-1273, there were increased risks of paresthesia (numbness and tingling) (vs. ChAdOx1nCov-19, OR: 2.37, 95% CI: 1.48-3.79); vertigo (vs. ChAdOx1nCov-19, OR: 1.68, 95% CI: 1.20-2.35); diplopia (double vision) (vs. ChAdOx1nCov-19, OR: 1.55, 95% CI: 0.67-3.57); and sleepiness (vs. ChAdOx1nCov-19, OR: 1.28, 95% CI: 0.98-1.67). In the period that ranged from March to August 2021, no one was hospitalized and/or died of severe complications related to the primary series of two COVID-19 vaccines. Hospitalization or death after one shot was not captured.”

Vaccination pages in VitaminDWiki includes:

Neurodevelopment of boys 2X more likely if low vitamin D

Neurodevelopmental problems 2X more likely in male infants if low vitamin D (Japan) – Oct 2023